Smoking cessation in severe mental illness: combined long-term quit rates from the UK SCIMITAR trials programme.
Br J Psychiatry
; 218(2): 95-97, 2021 02.
Article
en En
| MEDLINE
| ID: mdl-31685048
ABSTRACT
Smoking contributes to health inequalities for people with severe mental illness (SMI). Although smoking cessation interventions are effective in the short term, there are few long-term trial-based estimates of abstinence. The SCIMITAR trials programme includes the largest trial to date of a smoking cessation intervention for people with SMI, but this was underpowered to detect anticipated long-term quit rates. By pooling pilot and full-trial data we found that quit rates were maintained at 12 months (OR = 1.67, 95% CI 1.02-2.73, P = 0.04). Policymakers can now be confident that bespoke smoking cessation interventions produce successful short- and long-term quitting.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Cese del Hábito de Fumar
/
Trastornos Mentales
Tipo de estudio:
Diagnostic_studies
/
Systematic_reviews
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Br J Psychiatry
Año:
2021
Tipo del documento:
Article
País de afiliación:
Reino Unido